Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2026-01-01 @ 6:36 AM
Study NCT ID:
NCT04833205
Status:
UNKNOWN
Last Update Posted:
2021-04-20
First Post:
2021-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer
Sponsor:
Hui Bu
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-19
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-04-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-04-19
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-01
First Submit QC Date:
None
Study First Post Date:
2021-04-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-18
Last Update Post Date:
2021-04-20
Last Update Post Date Type:
ACTUAL